MA24736A1 - 2,3-SUBSTITUTED INDOLES AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS - Google Patents

2,3-SUBSTITUTED INDOLES AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS

Info

Publication number
MA24736A1
MA24736A1 MA25414A MA25414A MA24736A1 MA 24736 A1 MA24736 A1 MA 24736A1 MA 25414 A MA25414 A MA 25414A MA 25414 A MA25414 A MA 25414A MA 24736 A1 MA24736 A1 MA 24736A1
Authority
MA
Morocco
Prior art keywords
inflammatory
analgesic agents
substituted indoles
indoles
substituted
Prior art date
Application number
MA25414A
Other languages
French (fr)
Inventor
Uchida Chikara
William Stevens Rodney
Koike Hiroki
Nakao Kazunari
Caron Stephane
Kawamura Kiyoshi
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA24736A1 publication Critical patent/MA24736A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA25414A 1998-01-05 1999-01-04 2,3-SUBSTITUTED INDOLES AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS MA24736A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9800003 1998-01-05

Publications (1)

Publication Number Publication Date
MA24736A1 true MA24736A1 (en) 1999-10-01

Family

ID=11004645

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25414A MA24736A1 (en) 1998-01-05 1999-01-04 2,3-SUBSTITUTED INDOLES AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS

Country Status (39)

Country Link
US (1) US6608070B1 (en)
EP (1) EP1045833B1 (en)
JP (1) JP3347136B2 (en)
KR (1) KR100404054B1 (en)
CN (1) CN1284064A (en)
AP (1) AP869A (en)
AR (1) AR016977A1 (en)
AT (1) ATE308519T1 (en)
AU (1) AU748107B2 (en)
BG (1) BG104643A (en)
BR (1) BR9813124A (en)
CA (1) CA2316863A1 (en)
CO (1) CO4970807A1 (en)
DE (1) DE69832200T2 (en)
DZ (1) DZ2700A1 (en)
EA (1) EA200000614A1 (en)
ES (1) ES2255190T3 (en)
GT (1) GT199800205A (en)
HN (1) HN1997000098A (en)
HR (1) HRP20000454A2 (en)
HU (1) HUP0102922A3 (en)
ID (1) ID24876A (en)
IL (1) IL136885A0 (en)
IS (1) IS5532A (en)
MA (1) MA24736A1 (en)
NO (1) NO20003451L (en)
OA (1) OA11441A (en)
PA (1) PA8466201A1 (en)
PE (1) PE20000055A1 (en)
PL (1) PL341696A1 (en)
SA (1) SA99191299A (en)
SK (1) SK9912000A3 (en)
TN (1) TNSN99001A1 (en)
TR (1) TR200001906T2 (en)
TW (1) TW436482B (en)
UY (2) UY25332A1 (en)
WO (1) WO1999035130A1 (en)
YU (1) YU41600A (en)
ZA (1) ZA9911B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555540B1 (en) * 1999-06-30 2003-04-29 Pfizer Inc Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors
MXPA00006605A (en) 1999-07-02 2004-12-09 Pfizer Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents.
EP1065206B1 (en) * 1999-07-02 2002-10-09 Pfizer Inc. Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents
EA008242B1 (en) 1999-12-08 2007-04-27 Фармация Корпорейшн Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect and methods for treating diseases
EP1572678A4 (en) * 2002-12-19 2008-05-07 Elan Pharm Inc Substituted n-phenyl sulfonamide bradykinin antagonists
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
ES2275218T3 (en) 2003-05-07 2007-06-01 Osteologix A/S HYDROSOLUBLE STRONTIUM SALTS FOR THE TREATMENT OF CARTILAGOS AND / OR BONE AFFECTIONS.
KR100795462B1 (en) * 2006-09-27 2008-01-16 한국생명공학연구원 Indole derivatives, preparation methods thereof, and pharmaceutical compositions for the prevention and treatment of metabolic diseases containing the same as active ingredients
BRPI0718310A2 (en) 2006-10-17 2013-11-19 Stiefel Laboratories TALAROZOL METABOLITES
US20120022121A1 (en) * 2007-11-29 2012-01-26 Dalton James T Indoles, derivatives and analogs thereof and uses therefor
EP2560956B1 (en) * 2010-04-19 2016-10-26 Octeta Therapeutics, LLC Novel synthesis for thiazolidinedione compounds
JP5827328B2 (en) 2010-07-07 2015-12-02 アーデリクス,インコーポレーテッド Compounds and methods for inhibiting phosphate transport
EP2590656B1 (en) 2010-07-07 2017-11-15 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
JP5827326B2 (en) 2010-07-07 2015-12-02 アーデリクス,インコーポレーテッド Compounds and methods for inhibiting phosphate transport
JP5827327B2 (en) 2010-07-07 2015-12-02 アーデリクス,インコーポレーテッド Compounds and methods for inhibiting phosphate transport
PL2603507T3 (en) 2010-08-10 2016-12-30 Synthesis for thiazolidinedione compounds
HUE031424T2 (en) 2010-08-10 2017-07-28 Octeta Therapeutics Llc Novel synthesis for thiazolidinedione compounds
US10266490B2 (en) * 2012-03-16 2019-04-23 Georgetown University Radioprotector compounds
US9808443B1 (en) 2016-11-28 2017-11-07 King Saud University Cyclooxygenase inhibitors
CN111004121A (en) * 2019-12-09 2020-04-14 南京杰运医药科技有限公司 Preparation method of 4-alkoxy acetoacetic ester compound
CN112409281B (en) * 2020-08-20 2022-11-18 上海大学 Synthetic method of (E)-3-(3-chloro-2-fluoro-6-(1H-tetrazol-1-yl)phenyl)acrylic acid
CA3209491A1 (en) 2021-03-15 2022-09-22 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease
EP4353262A4 (en) * 2021-06-10 2025-05-21 UIF (University Industry Foundation), Yonsei University NOVEL COMPOUND EXHIBITING INHIBITORY ACTIVITY AGAINST PENDRIN, AND ITS PHARMACEUTICAL USES
CN116262721B (en) * 2023-01-12 2026-03-13 浙江师范大学 A dihydroindole derivative and its preparation method and product

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5604253A (en) * 1995-05-22 1997-02-18 Merck Frosst Canada, Inc. N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
US5510368A (en) * 1995-05-22 1996-04-23 Merck Frosst Canada, Inc. N-benzyl-3-indoleacetic acids as antiinflammatory drugs
CO5190664A1 (en) * 1999-06-30 2002-08-29 Pfizer Prod Inc COMBINATION THERAPY FOR THE TREATMENT OF MIGRANA ADMINISTRATION OF A 5HT RECEPTOR, CAFFEINE AND A CYCLLOXYGENASA-2 INHIBITOR

Also Published As

Publication number Publication date
IS5532A (en) 2000-06-13
ATE308519T1 (en) 2005-11-15
EA200000614A1 (en) 2001-02-26
KR100404054B1 (en) 2003-11-01
IL136885A0 (en) 2001-06-14
HN1997000098A (en) 1998-12-28
SK9912000A3 (en) 2001-11-06
UY25590A1 (en) 1999-09-27
HUP0102922A3 (en) 2003-06-30
AU748107B2 (en) 2002-05-30
OA11441A (en) 2004-04-27
BR9813124A (en) 2000-10-10
DZ2700A1 (en) 2003-09-01
HUP0102922A2 (en) 2001-12-28
WO1999035130A1 (en) 1999-07-15
JP3347136B2 (en) 2002-11-20
PE20000055A1 (en) 2000-02-08
YU41600A (en) 2003-08-29
TW436482B (en) 2001-05-28
NO20003451D0 (en) 2000-07-04
GT199800205A (en) 2000-06-21
EP1045833B1 (en) 2005-11-02
AU1500599A (en) 1999-07-26
AP869A (en) 2000-09-04
DE69832200T2 (en) 2006-04-20
EP1045833A1 (en) 2000-10-25
CN1284064A (en) 2001-02-14
JP2002500217A (en) 2002-01-08
NO20003451L (en) 2000-09-01
TR200001906T2 (en) 2001-01-22
ES2255190T3 (en) 2006-06-16
AR016977A1 (en) 2001-08-01
CO4970807A1 (en) 2000-11-07
US6608070B1 (en) 2003-08-19
BG104643A (en) 2001-02-28
AP9801423A0 (en) 1998-12-31
CA2316863A1 (en) 1999-07-15
DE69832200D1 (en) 2005-12-08
PA8466201A1 (en) 2000-09-29
PL341696A1 (en) 2001-04-23
UY25332A1 (en) 2001-01-31
HRP20000454A2 (en) 2001-04-30
KR20010033859A (en) 2001-04-25
ID24876A (en) 2000-08-31
TNSN99001A1 (en) 2005-11-10
ZA9911B (en) 2000-07-04
SA99191299A (en) 2005-12-03

Similar Documents

Publication Publication Date Title
DZ2700A1 (en) 2,3-substituted indoles serving as anti-inflammatory and analgesic agents.
EE9900256A (en) New compounds with analgesic properties
EE9900261A (en) New compounds with analgesic properties
DK1140935T3 (en) 1,2-celled quinoline derivatives
MA26848A1 (en) NEW HETEROCYCLO-ALKYLSUFONYLPYRAZOLE DERIVATIVES AS ANTI-INFLAMMATORY / ANALGESIC AGENTS.
ITMI981774A0 (en) PHARMACEUTICAL COMPOSITIONS WITH ANALGESIC ACTIVITY
DE69832982D1 (en) DOLASTATINE 15 DERIVATIVES
NO984290D0 (en) Pharmaceutically useful compounds
NO994663L (en) Analgesic combination
IT1291709B1 (en) ANALOGHI DI BUPRENORFINA HAVING ANALGESIC PROPERTIES.
ATE267196T1 (en) SULFONYLBENZENE COMPOUNDS AS ANALGESIC AND ANTI-INFLAMMATORY AGENTS
NO20004277L (en) Indole derivatives and pharmaceutical compositions comprising the same
ITMI962423A0 (en) ORAL PHARMACEUTICAL COMPOSITION WITH ANTIPYRETIC, ANALGESIC AND INFLAMMATORY ACTIVITY
FR2774673B1 (en) CALIPER WITH PIVOTING FOOTREST
EP1052221A4 (en) OZONE GENERATOR
EE200100281A (en) Analgesic pharmaceutical composition
EP1157697A4 (en) REMEDIES FOR HYPERAMMONIA
BR9709521A (en) "3-Cyanoaryl-pyrazoles"
ATE243218T1 (en) 2''-DEOXYHYGROMYCIN DERIVATIVES
BR9708948A (en) 1,3 - Substituted benzodioxols
UA2402S (en) "TUTTI-FRUTTI" BOTTLE
FR2792675B1 (en) CENTRAL OPENING COMPOSITE AMOUNT
DK1175397T3 (en) 3,3-substituted indoline derivatives
UA3201S (en) BOTTLE "JEMAN"
UA3762S (en) BOTTLE "NEZHYNSKA RABYNA"